Analysis
Menlo Ventures has closed $3 billion in new capital, the largest fundraise in its 50-year history, according to TechCrunch and Crunchbase News. The haul is a direct dividend of the firm's aggressive 2024 wager on Anthropic, a position now valued at roughly $14 billion -- a return that has reshaped Menlo's standing among AI-era venture firms.
The bet was not obvious at the time. Menlo led a $750 million investment in Anthropic in 2024, structuring it as roughly $500 million through a special purpose vehicle and about $250 million from its own fund plus insider contributions. Partners later described the period as 'white-knuckling it' -- the kind of concentrated, firm-defining call that looks visionary in hindsight and reckless if it fails. It did not fail: Anthropic's valuation has since soared toward the trillion-dollar tier, and Menlo doubled down through subsequent Series E and F rounds.
“Menlo's $3 billion is the receipt for exactly that behavior -- and a template every GP raising in 2026 will be measured against.”
The firm also built a structural moat around the lab. Menlo co-launched the $100 million 'Anthology' fund with Anthropic to back startups building on Claude; that vehicle has since grown to roughly $250 million deployed across more than 60 portfolio companies, including names like OpenRouter, Higgsfield, Legora, Lovable and OpenEvidence. Several have already produced exits, with Graphite acquired by Cursor and Astrix Security by Cisco.
The new $3 billion gives Menlo the firepower to write larger checks across stages at a moment when AI valuations remain stretched and the best rounds are fiercely contested. It is a vote of confidence from limited partners that the firm's AI thesis -- and its privileged position inside the Anthropic ecosystem -- has durability beyond a single markup.
The broader signal is about how venture returns are now made. In a cycle defined by a handful of generational AI franchises, the firms winning biggest are the ones that placed early, concentrated bets and had the nerve to hold and add. Menlo's $3 billion is the receipt for exactly that behavior -- and a template every GP raising in 2026 will be measured against.
